Pricing Log in Create free account

Ascentage Pharma Group International - Unsponsored ADR (AAPG) vs Ocular Therapeutix, Inc. (OCUL)

Ascentage Pharma Group International - Unsponsored ADR and Ocular Therapeutix, Inc. are both Biotechnology companies. Ascentage Pharma Group International - Unsponsored ADR and Ocular Therapeutix, Inc. are of similar size ($1.4B and $1.4B). Across the 8 metrics below, Ascentage Pharma Group International - Unsponsored ADR leads on 5 and Ocular Therapeutix, Inc. on 3.

Valuation

Metric AAPG OCUL Biotechnology median
P/E — n/m 10.60
P/S — 28.61 9.40
P/B n/m 2.86 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 18.51 9.02
Earnings yield — (21.45%) (32.88%)
Free cash flow yield 0.00% (17.13%) (23.13%)

Profitability

Metric AAPG OCUL Biotechnology median
Gross margin — 87.11% 68.51%
Operating margin — (603.04%) 0.00%
Net margin — (579.10%) 0.00%
Free cash flow margin 0.00% (490.07%) 0.00%
Return on equity 0.00% (72.99%) (51.96%)
Return on assets 0.00% (53.70%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AAPG OCUL Biotechnology median
Revenue growth (TTM) — (8.14%) 6.76%
EPS growth (last fiscal year) (177.78%) (16.39%) 29.88%
Revenue growth, 5-year CAGR — 24.45% 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric AAPG OCUL Biotechnology median
Debt to equity 3.70 0.14 0.00
Current ratio 1.22 13.11 4.97
Net debt to EBITDA 0.44 2.51 1.01

Dividend

Metric AAPG OCUL Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric AAPG OCUL Biotechnology median
Market cap 1.41b 1.41b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack